1. Home
  2. Browse Decisions
  3. F.3d
  4. 927 F.3d
  5. 927 F.3d 1272 (2019)
 

UCB, INC. v. WATSON LABORATORIES INC.

2018-1397, 2018-1453.

927 F.3d 1272 (2019)

UCB, INC., UCB Manufacturing Ireland Limited, UCB Pharma GMBH, LTS Lohmann Therapie-Systeme AG, Plaintiffs-Cross-Appellants v. WATSON LABORATORIES INC., Actavis Laboratories UT, Inc., Defendants-Appellants

United States Court of Appeals, Federal Circuit.

Decided: June 24, 2019.

Attorney(s) appearing for the Case

Jack B. Blumenfeld , Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE, argued for plaintiffs-cross-appellants. Also represented by Derek J. Fahnestock , Maryellen Noreika; James Trainor , Robert Counihan , Adam Gahtan , Kevin Mcgann , Silvia Medina , Fenwick & West LLP, New York, NY.

John C. O'Quinn , Kirkland & Ellis LLP, Washington, DC, argued for defendants-appellants. Also represented by William H. Burgess , Calvin Alexander Shank ; Leora Ben-Ami , Thomas F. Fleming , Christopher T. Jagoe , New York, NY.

Before Taranto, Schall, and Chen, Circuit Judges.

This appeal concerns UCB, Inc., UCB Manufacturing Ireland Limited, UCB Pharma GmbH, and LTS Lohman Therapie-Systeme AG (UCB)'s U.S. Patent Nos. 6,884,4341 and 8,232,414.2 The '434 patent claims a transdermal therapeutic system comprising rotigotine, a drug used for the...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases